Manmeet Singh Soni

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Sunnyvale, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Kenneth B. Stratton
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Manmeet Singh Soni

Form 4 holding COO and CFO, Director

Summit Therapeutics Inc.

Security class
Stock Option (right to buy)
Shares / value
11,200,000
Estimated value
$1,452,000
Report date
29 Apr 2025
Price
$1.32
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding COO, CFO and President

REATA PHARMACEUTICALS INC

Security class
Class A common stock
Shares / value
0
Estimated value
Report date
26 Sep 2023
Price
$172.03
Ownership
Direct
Form 4 holding COO, CFO and President

REATA PHARMACEUTICALS INC

Security class
Employee Stock Option (right to buy)
Shares / value
0
Estimated value
Report date
26 Sep 2023
Price
Ownership
Direct
Underlying class
Class B common stock
Underlying amount

Insider Reports Filed by Manmeet Singh Soni

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .